Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:27 Jul 2017 12:15:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1623.40 [ +0.04% ]TCS 2543.45 [ -0.49% ]

Sensex32654.15
271.69 0.84%

Nifty10106.40
85.75 0.86%

Midcap15398.88
59.12 0.39%

Smallcap16112.67
14.03 0.09%



Cipla Ltd :

 570.90  -3.90 [-0.68%]

ISIN: INE059A01026  | NSE: CIPLA |  Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln  |  BSE Code: 500087  |  Add To Watchlist

Price Information
• Open 576.00
• High 576.00
• Low 568.00
• Previous Close 574.80
• Shares Traded 3094900
• 52 Wk High Price 621.90
• 52 Wk High Date 06-02-2017
• 52 Wk Low Price 479.00
• 52 Wk Low Date 26-05-2017
• Face Value 2.00


Fundamentals
• Market Capital (Rs.cr) 45830.20
• EPS (Rs.)(TTM) 11.80
• P/E Ratio(TTM) 48.30
• Book Value (Rs.) 159.10
• Price to Book Value 3.58
• Equity (Rs.cr.) 160.93
• Traded Value (Rs.lac) 387.07


Corporate Actions
Ex-Date Purpose (Rs.)
2011-08-09 100% Final Dividend (2)
2012-08-01 100% Dividend (2)
2013-08-06 100% Divided (2)
2014-08-06 100% dividend (2)
2015-08-11 100% Dividend (2)
2016-09-12 100% Dividend (2)
2017-07-26 100% Dividend (2)


Index Names
BSE Sensex
BSE-200
BSE-500
BSE-100
BSE HC
CNX Nifty


Related Companies
Stock Name Price
BAJAJTEMPO 4090.75




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Mar, 2017 Mar, 2017 Mar, 2017
• Sales (Rs.cr) 2608.51 10974.60 10974.60
• Net Profit (Rs.cr) 25.86 952.71 952.71
• Net Profit Var (%) 181.00 -32.00 -32.00
• EPS (Rs) - 11.80 11.80
• P/E Ratio - 48.30 48.30
• Operating Profit Margin - 14.50 -
• CPS (Rs.) - - 18.10
• P/C Ratio - - 31.50
• Div% - - 100.00

Announcements
25-05-2016 Board of Cipla recommends final dividend
10-12-2010 Amar Lulla ceases as joint managing director of Cipla
24-07-2014 Board of Cipla appoints director
20-12-2016 Board of Cipla approves raising of funds upto Rs 4000 crore
18-02-2016 Cipla acquires two US based companies
06-07-2017 Cipla allots 1,15,611 equity shares
24-01-2017 Cipla allots 19,128 equity shares
16-03-2017 Cipla allots 38,333 equity shares
26-04-2017 Cipla allots 39,601 equity shares
08-02-2017 Cipla allots 39691 equity shares
25-05-2017 Cipla allots 7949 equity shares
02-07-2015 Cipla allots equity shares
29-05-2015 Cipla announces cessation of director and CFO
01-08-2016 Cipla announces change in Global CFO
08-09-2014 Cipla announces commercial collaboration with S&D Pharma
23-07-2014 Cipla announces resignation of director
15-11-2011 Cipla appoints additional director
07-11-2015 Cipla appoints director
22-11-2012 Cipla appoints Subhanu Saxena as CEO
17-07-2014 Cipla becomes sublicensing partner of the Medicines Patent Pool
21-02-2011 Cipla get tentative approval for Abacavir Sulphate
23-04-2011 Cipla gets tentative approval for the Rizatriptan Benzonate
10-04-2013 Cipla grants stock options
17-02-2017 Cipla launches adult Hepatitis B vaccine
15-12-2016 Cipla provides update on subsidairy - Cipla Netherlands
13-04-2016 Cipla provides update on subsidiary
09-06-2017 Cipla provides update on subsidiary - Saba Investments
30-11-2015 Cipla ready to launch low-dose Efavirenz 400 mg
13-10-2016 Cipla receives EIR for its Indore facility
08-06-2012 Cipla recommends dividend
20-07-2017 Cipla schedules board meeting
06-10-2014 Cipla signs definitive agreement with Iranian distributor
01-04-2017 Cipla to acquire South African Pharma company- Anmarate
28-07-2011 Cipla to announce Q1 results
03-11-2010 Cipla to announce Q2 results
03-02-2012 Cipla to announce Q3 results
07-10-2015 Cipla to establish JV in Algeria
05-08-2014 Cipla to hold AGM
22-05-2013 Cipla To Hold Board Meeting
04-03-2015 Cipla updates on Stempeutics Research, a JV with Cipla Group
21-07-2015 Outcome of board meeting of Cipla

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
25-07-2017 9755 37251 26.19 5506698 21077.70
24-07-2017 13908 67892 20.49 7921302 38707.00
21-07-2017 12262 47320 25.91 6941519 26719.20
20-07-2017 20330 80740 25.18 11620628 46238.60
19-07-2017 15367 48668 31.58 8730762 27586.80


Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  natura  •  moto  •  hindustan m  •  gvk power  •  comp
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech